Alzheimer's disease (AD) is a major public health issue facing the world's aging population;however, to date, there is no rapid and cost effective means for early diagnosis that is widely accessible. It has been suggested that a blood-based screening will become the first-step in the AD diagnostic process, although no such test currently exists. In our prior work through the Texas Alzheimer's Research &Care Consortium (TARCC), we created a serum-based screening algorithm that correctly classified 94% of those with and without AD. We then followed that work-up by creating a blood-based algorithm in the TARCC that worked across both serum and plasma that, when applied to the ADNI plasma samples, correctly classified 89% of those with and without AD in the entirely independent cohort. The long-term goal of this project is the validation of the our blood-based screening instrument for AD.
The specific aims of the current project are as follows:
Specific Aim 1 : To test the reliability and validity of our previously created blood-based screening algorithm, and Specific Aim 2: To validate our blood-based algorithms against other diagnostic modalities (i.e., neuropathological findings and CSF analyses). Multiplex serum- and plasma-based biomarker assays (using electrochemiluminescence) will be conducted on 1,100 samples from the TARCC and Mayo Clinic Jacksonville biobanks. The establishment of a blood-based screening instrument for AD will significantly change the field of geriatric medicine. Such a tool would fit into the existing medical infrastructure as a frontline population-based screening device where positive findings can be followed-up with clinical, imaging or CSF assessments. This overall approach will increase accessibility to standard care far beyond what can be offered by other methodologies. This approach will also provide a more rapid and cost-efficient means for screening into AD clinical trials.

Public Health Relevance

Alzheimer's disease (AD) is a major public health issue facing the world's aging population;however, to date, there is no rapid and cost effective means for screening all those at risk for having the disease. The relevance of the current proposal is the establishment of a blood-based screener for AD that can be used and implemented as a frontline assessment device for clinical and research purposes. The establishment of a blood-based screener for AD would change the field of geriatric medicine and increase access to care globally.

National Institute of Health (NIH)
National Institute on Aging (NIA)
Research Project (R01)
Project #
Application #
Study Section
Clinical Neuroscience and Neurodegeneration Study Section (CNN)
Program Officer
Hsiao, John
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of North Texas
Internal Medicine/Medicine
Schools of Osteopathic Medicine
Fort Worth
United States
Zip Code
Henriksen, Kim; O'Bryant, Sid E; Hampel, Harald et al. (2014) The future of blood-based biomarkers for Alzheimer's disease. Alzheimers Dement 10:115-31
Edwards, Melissa; Balldin, Valerie Hobson; Hall, James et al. (2014) Combining select neuropsychological assessment with blood-based biomarkers to detect mild Alzheimer's disease: a molecular neuropsychology approach. J Alzheimers Dis 42:635-40
Falkowski, Jed; Atchison, Timothy; Debutte-Smith, Maxine et al. (2014) Executive functioning and the metabolic syndrome: a project FRONTIER study. Arch Clin Neuropsychol 29:47-53
Cunningham, Rebecca L; Singh, Meharvan; O'Bryant, Sid E et al. (2014) Oxidative stress, testosterone, and cognition among Caucasian and Mexican-American men with and without Alzheimer's disease. J Alzheimers Dis 40:563-73
O'Bryant, Sid E; Xiao, Guanghua; Zhang, Fan et al. (2014) Validation of a serum screen for Alzheimer's disease across assay platforms, species, and tissues. J Alzheimers Dis 42:1325-35
O'Bryant, Sid E; Xiao, Guanghua; Barber, Robert et al. (2014) Molecular neuropsychology: creation of test-specific blood biomarker algorithms. Dement Geriatr Cogn Disord 37:45-57
Edwards, Melissa; Hall, James; Gong, Gordon et al. (2014) Arsenic exposure, AS3MT polymorphism, and neuropsychological functioning among rural dwelling adults and elders: a cross-sectional study. Environ Health 13:15
Johnson, Leigh A; Cushing, Blair; Rohlfing, Geoffrey et al. (2014) The Hachinski ischemic scale and cognition: the influence of ethnicity. Age Ageing 43:364-9
Roane, Brandy M; Johnson, Leigh; Edwards, Melissa et al. (2014) The link between sleep disturbance and depression among Mexican Americans: a Project FRONTIER study. J Clin Sleep Med 10:427-31
Edwards, Melissa; Johnson, Leigh; Mauer, Cortney et al. (2014) Regional specific groundwater arsenic levels and neuropsychological functioning: a cross-sectional study. Int J Environ Health Res 24:546-57

Showing the most recent 10 out of 20 publications